Etiometry: Raises $9M in Series A-3 Funding
- Etiometry, a Boston, MA-based provider of clinical decision-support software for the intensive care environment, raised $9M in Series A-3 funding
- The round was led by SKK 9i Ventures, with participation from Shamrock Holdings and other healthcare investors
- The funds will be used to help extend use of the company’s software to other hospital care settings
- Led by Shane Cooke, CEO, the company provides clinical decision-support software for the intensive care environment
- The software aggregates patients vital signs from multiple sources into one streamlined platform to help clinicians understand evolving clinical risks
- The company obtained its sixth 510(k) clearance from the FDA in 2020 and anticipates its seventh clearance to be granted in the second half of 2021 for new risk algorithms
